Epigenetic signatures and cardiovascular risk in diabetes.
Session:
How do SGLT2 inhibitors and incretin-based therapy exert their effects on cardiovascular disease?
Topic:
Metabolic Syndrome, Insulin, Insulin Resistance
Event:
ESC Congress 2018
Congress Presentation
About the speaker
Professor Francesco Cosentino
Karolinska University Hospital, Stockholm (Sweden)
24
presentations
0
follower
3 more presentations in this session
Access the full session
How do SGLT2 inhibitors and incretin-based therapy exert their effects on cardiovascular disease?
Speakers:
Professor F. Cosentino, Professor L. Ryden, Professor B. Staels, Professor E. Ferrannini
About the event
ESC 365 is supported by
